MAR — Marriott International, Inc.

Q2 2026 adjusted EPS of $3.19 beat consensus by ~$0.11, gross fee revenue rose 13%, and adjusted EBITDA rose 13%, but Q3 EPS guidance of $2.74-$2.82 came in softer than expected and international RevPAR fell 0.5% on a 43% Middle East plunge, triggering a ~7% post-earnings selloff. Analyst positioning is mixed-positive (23 buys vs 28 holds, consensus target ~$389), so sentiment is cautious-neutral rather than bullish.

Revenue growth has been steady but not accelerating: YoY growth was +4.7% in Q2'25, +3.7% in Q3'25, +4.1% in Q4'25, +6.2% in Q1'26, and +4.8% in Q2'26. GAAP net income is essentially flat year-over-year — Q2'26 net income was $766M vs $763M a year earlier, diluted EPS $2.84 vs $2.78 — because the faster growth is in fees/adjusted EBITDA (+13%) rather than total revenue. Operating margin ticked down from 18.3% in Q2'25 to 17.4% in Q2'26, though Q4 prints are seasonally noisy (Q4'25 operating margin was only 11.6%). The cleaner positive is cash flow: 2026 H1 operating cash flow is up more than 30% YoY and Q2'26 FCF was $796M. Overall: stable, high-quality, but not showing an inflection.

As of 2026-08-27, MAR is not cheap. TTM P/E is 36.9x vs its own 5-year average of 31.5x, and P/S is 3.43x vs 3.09x. On 2026 consensus EPS of $11.71, the forward P/E is ~30.2x — roughly in line with history if the 16-18% adjusted EPS growth is delivered. PEG on forward growth is ~1.8x, and the balance sheet is heavily leveraged with negative stockholders' equity, though the asset-light model offsets some of that risk. Net read: fair-to-rich; the 'Rich vs. its own history' label is appropriate on trailing metrics.

At $353.87, the market is paying ~30x estimated 2026 EPS for a company guiding to 16-18% adjusted EPS growth. That is a reasonable but not bargain entry; the stock already capitalizes much of the 2026 earnings recovery and the JPMorgan/Amex credit card fee uplift. Q3 guidance of $2.74-$2.82 is a step down from Q2's $2.84 GAAP / $3.19 adjusted, so near-term earnings momentum is soft. Unless Q3 beats or international RevPAR stabilizes, MAR is more likely to consolidate in the $330-$360 range than break out; a miss could push it toward the low-$300s.

As of 2026-08-27, RSI is 43.2 — weak but not oversold — and price is 0.6% below the 20-day, 3.8% below the 50-day, but 3.1% above the 200-day. That reflects a long-term uptrend with a short-term pullback/consolidation rather than a confirmed reversal. The 200-day area near ~$343 is the first meaningful support, and a reclaim of the 50-day would signal the post-earnings digestion is over. No urgency to buy based purely on technicals.

• Resilient US consumer and solid high-end/luxury travel demand, supporting US & Canada RevPAR growth of 5.0% in Q2'26.
• Middle East geopolitical conflict: regional RevPAR plunged 43% and is delaying net rooms growth toward the low end of guidance.
• Interest rates and capital costs: asset-light franchise model reduces direct real estate exposure, but financing conditions still affect developer pipeline and consumer discretionary spending.
• Credit card/rewards partnership economics: expanded JPMorgan and Amex agreements add a durable, high-margin fee stream.
• China/Asia-Pacific travel recovery trajectory remains a swing factor for international RevPAR and longer-term pipeline conversion.

• Q3 2026 earnings (late Oct/early Nov 2026): actual results vs guided EPS of $2.74-$2.82 and any change to full-year RevPAR guidance.
• Stabilization of international RevPAR, especially Middle East, and evidence that net rooms growth recovers toward the 4.5-5% range.
• Co-brand credit card fee ramp: ~$30M of incremental fees in H2 2026, scaling to $100-$125M annual by 2028.
• Continued shareholder returns: Marriott plans to return over $4.5B in 2026 via buybacks and dividends.
• Record development pipeline of ~629,000 rooms converting into openings and fee growth.

• US consumer recession or slowdown that hits high-end travel demand and RevPAR.
• Escalation of Middle East conflict causing prolonged regional revenue destruction and development delays.
• Further weakness in international/China travel demand compressing global RevPAR.
• Valuation/multiple compression risk given TTM P/E of 36.9x and 'Rich vs. its own history' label.
• Highly leveraged balance sheet: $16.5B long-term debt, negative stockholders' equity, $462M cash, and 0.54 current ratio leave limited cushion if FCF deteriorates.

Marriott is a genuinely high-quality asset-light compounder with a record pipeline, strong fee growth, durable co-brand card economics, and robust free cash flow. But at roughly 30x forward earnings and a rich valuation versus its own history, most of that quality is already in the price. With soft Q3 guidance and negative international RevPAR, the risk/reward is balanced rather than compelling — I would not chase at $353.87; a better entry is closer to $330-$345 or after Q3 proves international stabilization.

I applied Marriott's 5-year average P/E of 31.5x to 2026E consensus EPS of $11.71, which gives $369; I then discounted ~5% to $350.70 for Middle East RevPAR drag, soft Q3 guidance, and slower net rooms growth. The resulting fair value is intentionally close to the current price, reflecting that MAR is fairly valued rather than cheap or expensive.